{"id":"W2162200636","doi":"10.1634/theoncologist.2013-0160","title":"Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines","year":2013,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01089405,0.0003180244,0.0003695488,0.0105452,0.001040458,0.004335884,0.0003517359,0.0005319785,0.00215554],"category_scores_gemma":[0.04905777,0.0003294265,0.000398808,0.0100311,0.001762389,0.003589609,0.001598312,0.0005717556,0.0005245921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001193566,"about_ca_system_score_gemma":0.001066846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0012584,"about_ca_topic_score_gemma":0.003296736,"domain_scores_codex":[0.9904947,0.003712991,0.001865142,0.0005059803,0.003110037,0.0003111249],"domain_scores_gemma":[0.8449332,0.08783744,0.05383379,0.002282439,0.009270593,0.001842587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009398606,0.0001228257,0.520532,0.009190016,0.0004471715,0.002060237,0.08555444,0.00008310551,0.004728073,0.003698321,0.03496096,0.337683],"study_design_scores_gemma":[0.00003527175,0.0003060378,0.7596288,0.005754208,0.0004184335,0.004071894,0.09865356,0.0003112765,0.001626544,0.001525158,0.1275651,0.0001037284],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.9019551,0.05204525,0.0024414,0.01602693,0.001077214,0.0004068814,0.003794087,0.0001547773,0.0220983],"genre_scores_gemma":[0.9619662,0.02339649,0.003400224,0.004355551,0.002028538,0.0002769835,0.001822037,0.00008091116,0.002673074],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.01089405,"threshold_uncertainty_score":0.05761391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02457483905182569,"score_gpt":0.3578842586752508,"score_spread":0.3333094196234251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}